Syntax Research, Inc.
- SEC CIK
- 0001999827
- Latest filing
- Jul 31, 2026
LXRX holding history
Lexicon Pharmaceuticals, Inc. in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 142
- Value
- $341
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 142 | $341 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 142 | $222 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 142 | $164 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 142 | $192 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 142 | $135 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 142 | $66 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 142 | $105 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 142 | $223 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 142 | $239 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 142 | $341 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 142 | $218 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 142 | $155 | <0.1% | – | No prior filing | Holders |